XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Unaudited Consolidated Statements of Cash Flows - CAD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Operating activities        
Loss for the quarter $ (14,891,853) $ (5,333,621) $ (29,736,379) $ (22,682,124)
Adjustments for:        
Amortization 592,057 268,932 1,037,244 798,912
Stock-based compensation expense 2,980,352 1,597,779 6,930,434 4,148,806
Share-based payment expense   (39,426)   206,516
Interest income (93,024) (152,561) (145,687) (94,478)
Lease modification loss 32,486   32,486  
Changes in fair value of derivative liability 4,846,725 (2,107,474) 7,758,928 3,412,917
Deferred income tax recovery (11,330) (6,894) (38,605) (56,069)
Changes in non-cash working capital items:        
Receivables 71,042 1,448,744 221,915 932,425
Prepaid expenses (529,435) 851,321 (277,225) (3,959,468)
Inventory (66,750) 198,103 (626,257) (444,079)
Trade payables and accrued liabilities (124,733) 391,756 (1,403,801) (93,305)
Customer deposits and construction contract liability (46,637) 41,522 35,316 97,256
Net cash flows used in operating activities (7,241,100) (2,841,819) (16,211,631) (17,732,691)
Investing activities        
Investments in restricted cash 1,893 (589) (2,256) 1,042
Expenditures on plant and equipment (476,396) (2,147,066) (816,280) (3,415,881)
Acquisition of intangible assets   (13,050)   (5,008)
Net cash flows used in investing activities (474,503) (2,160,705) (818,536) (3,419,847)
Financing activities        
Interest received 13,361 58,605 207,227 70,692
Interest from net investment in sublease 1,461   10,456  
Interest paid (8) (258) (403) (408)
Interest on lease payments (24,923) (36,488) (81,274) (104,673)
Repayment of shareholder loans   (1,038) (2,076) (3,115)
Repayment of leases (168,782) (151,462) (461,454) (451,109)
Payment received for net investment in sublease 11,860   71,324  
Proceeds on issuance of common shares - net of issue costs 52,838,472 (15,699) 102,369,062 14,699,097
Proceeds from issuance of common shares for options exercised 88,643   96,143 35,008
Proceeds from issuance of common shares for warrants exercised 4,669,929   4,819,929 4,195,286
Net cash flows from /(used in) financing activities 57,430,013 (146,340) 107,028,934 18,440,778
Increase/(decrease) in cash and cash equivalents 49,714,410 (5,148,864) 89,998,767 (2,711,760)
Effect of exchange rate changes on cash 87,781 (14,257) (39,672) 10,330
Cash and cash equivalents, beginning 51,252,752 21,388,624 11,095,848 18,926,933
Cash and cash equivalents, ending $ 101,054,943 $ 16,225,503 $ 101,054,943 $ 16,225,503